| List of Contributors | |
| Foreword | |
| Preface | |
| Introduction | |
| What's new in cardiac imaging? | p. 3 |
| Why new cardiac imaging agents? | p. 17 |
| Perfusion | |
| The value of measuring myocardial perfusion in coronary artery disease | p. 33 |
| Single photon imaging | |
| Myocardial perfusion imaging with xenon-133 | p. 41 |
| Myocardial perfusion and krypton-81m | p. 49 |
| Myocardial perfusion imaging with technetium-99m isonitriles: attractive thallium substitutes? | p. 69 |
| Is there a specific role for technetium-99m SestaMIBI in the assessment of cardiac arrhythmias? | p. 87 |
| Technetium-99m complexes of functionalized diphosphines for myocardial perfusion imaging in man | p. 93 |
| Myocardial perfusion imaging with technetium-99m teboroxime | p. 111 |
| Positron emission tomography | |
| Clinical applications of rubidium-82 myocardial perfusion imaging | p. 127 |
| Nitrogen-13 ammonia perfusion imaging | p. 143 |
| Quantification of myocardial perfusion with oxygen-15 water | p. 157 |
| Myocardial perfusion imaging with copper-62 labeled Cu-PTSM | p. 165 |
| Magnetic resonance imaging | |
| Application of contrast agents in magnetic resonance imaging: additional value for detection of myocardial ischemia? | p. 179 |
| Magnetic resonance imaging using paramagnetic contrast agents in the clinical evaluation of myocardial infarction | p. 201 |
| Metabolism | |
| Assessment of myocardial metabolism in vivo, a biochemist's view | p. 223 |
| Single photon imaging | |
| Myocardial metabolic imaging with iodine-123 fatty acids | p. 229 |
| Positron emission tomography | |
| Assessment of myocardial fatty acid metabolism with carbon-11 palmitate | p. 249 |
| Myocardial metabolic imaging with fluorine-18 deoxyglucose | p. 263 |
| Myocardial metabolic imaging with carbon-11-acetate | p. 277 |
| Infarct-avid imaging | |
| Single photon imaging | |
| Infarct-avid imaging: usefulness, problems and limitations | p. 289 |
| Myocyte necrosis-avid with radiolabeled antimyosin antibody: experimental and clinical acute myocardial infarction, myocarditis and heart transplant rejection | p. 295 |
| Myocardial infarct imaging with cardiac troponin-I antibodies | p. 317 |
| Function | |
| Single photon imaging, positron emission tomography | |
| Radionuclide imaging in the evaluation of cardiac function: new developments? | p. 329 |
| Single photon imaging | |
| Krypton-81m equilibrium radionuclide ventriculography for the assessment of right ventricular function | p. 341 |
| Simultaneous assessment of myocardial function and perfusion | p. 353 |
| Sympathetic nerve system | |
| Single photon imaging | |
| Radiolabeled metaiodobenzylguanidine (I-123 MIBG): value in clinical cardiology? | p. 369 |
| Scintigraphic assessment of cardiac innervation using iodine-123 metaiodobenzylguanidine | p. 377 |
| Clinical experience with iodine-123 metaiodobenzylguanidine | p. 387 |
| Positron emission tomography | |
| Studies of cardiac receptors by positron emission tomography | p. 399 |
| Heart neuronal imaging with carbon-11- and fluorine-18-labeled tracers | p. 413 |
| Leukocytes, platelets, lipoproteins | |
| Single photon imaging | |
| Labeling of leukocytes, platelets, and lipoproteins: useful in clinical cardiology? | p. 429 |
| Indium-111 leukocyte scintigraphy for detection of valvular abscesses and vegetations | p. 437 |
| Detection of cardiac thrombi with indium-111 platelet scintigraphy | p. 447 |
| Scintigraphic detection of atherosclerosis with radiolabeled low density lipoprotein | p. 455 |
| Viability | |
| Single photon imaging, positron emission tomography, magnetic resonance imaging | |
| Assessment of myocardial viability with scintigraphic techniques and magnetic resonance imaging: new attainments? | p. 467 |
| Positron emission tomography | |
| Is it worth assessing regional myocardial viability with positron emission tomography? | p. 479 |
| Assessment of tissue viability after myocardial infarction with fluorine-18 deoxyglucose using planar imaging; the alternative approach | p. 493 |
| Alternative stress imaging Single photon imaging, echocardiography, magnetic resonance imaging | |
| New developments in pharmacological stress imaging | p. 503 |
| Index | p. 539 |
| Table of Contents provided by Blackwell. All Rights Reserved. |
